The approval for SC injection was based on data from the open-label extension of the phase 3 CLARITY AD trial.

The Food and Drug Administration (FDA) has approved Wayrilz ™ (rilzabrutinib) for adults with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous ...

Later in a statement Mr Zaid, with his fellow attorney Abbe Lowel, wrote that Dr Monarez “refused to rubberstamp unscientific, reckless directives” and “has neither resigned nor received notification ...

The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous ...

The 7-year analysis also demonstrated sustained invasive disease-free survival and distant relapse-free survival benefit.

The Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines Spikevax ® and mNexspike ®. The updated mRNA vaccines target the LP.8.1 variant of ...

In May 2025, the FDA’s Vaccines and Related Biological Products Advisory Committee unanimously voted to recommend a monovalent JN.1-lineage COVID-19 vaccine composition for use in Fall 2025. The ...

HealthDay News — Spironolactone does not reduce a composite outcome of cardiovascular mortality and hospitalization due to heart failure among patients receiving maintenance dialysis, according to a ...

The Food and Drug Administration (FDA) has approved the 2025-2026 formulation of Nuvaxovid ™ (COVID-19 Vaccine, Adjuvanted).

The Food and Drug Administration (FDA) has updated the risk evaluation and mitigation strategy (REMS) labeling for Filspari ® (sparsentan) to decrease the frequency of liver function monitoring and ...

HBOT uses a pressurized chamber to deliver 100% oxygen, helping the lungs absorb more oxygen to support healing and fight infections, according to the FDA.

HealthDay News — Popular chatbots generally perform well in responding to very high-risk and very low-risk questions about suicide, according to a study published online August 26 in Psychiatric ...